期刊档案 · Medicine-Pharmacology (medical)
Research Results in Pharmacology
ISSN 2658-381X · Belgorod State National Research University · Bulgaria
Research Results in Pharmacology 钻石开放获取(无 APC),免版面费,投稿社区反馈审稿约 12 周,2025 年发文 58 篇,Scopus 收录。
研究范围
研究范围与定位
Research Results in Pharmacology 由 Belgorod State National Research University 出版。按 OpenAlex 近年发文统计,该刊主要发表 Neurological Disorders and Treatments、Nitric Oxide and Endothelin Effects、Synthesis and biological activity 等主题的论文,这 3 个主题约占 23%,主导子领域为 Cellular and Molecular Neuroscience。(根据 OpenAlex 主题统计与中科院分区数据生成)
Research Results in Pharmacology is a peer-reviewed, open access, online journal covering various aspects of pharmacology. The Journal publishes articles in the field of pharmacotherapy, pharmacokinetics, pharmacoepidemiology, personalized therapy, multicenter studies, molecular screening, evidence-based medicine, proteomics, cellular technologies, results of experimental studies in modeling abnormalities in laboratory animals and clinical studies. Research Results in Pharmacology is established to facilitate the international cooperation in pharmacological research through: (1) English-language publication of high-quality work performed in Russia and other neighboring countries, following the highest possible publishing standards, and (2) involvement of foreign researchers in joint scientific and publication projects. Research Results in Pharmacology is a diamond open access journal, which means it is free to publish, read, distribute and re-use, thanks to the financial support of the Belgorod National Research University (BelSU). The articles are published online when ready in four issues a year. Research Results in Pharmacology will consider for publication articles on: promising pharmacological targets, highly efficient molecular screening with the use of modern methods of proteomics, cellular technologies, experimental studies in modeling abnormalities in laboratory animals, new experimental models on transgenic animals and their use in experimental pharmacology, historical issues of experimental and clinical pharmacology, structure-action analysis of innovative molecules and forecasting pharmacological activity, issues of metabolomics, clinical studies in the field of pharmacotherapy, pharmacokinetics, pharmacoepidemiology, personalized therapy, multicenter studies and evidence-based medicine. The following categories of articles will be considered: original research articles, reviews - longer articles, offering a comprehensive overview, historical analysis or/and future perspectives of a topic, short communications, discussion papers, methods, data papers, book reviews, monographs and collections of papers with no limit in size, published as 'special issues’. The Journal publishes electronic versions of the articles when these are ready to publish, without delays that might be caused by the completion of an issue. These electronic versions are not "pre-prints" but final and immutable versions of record. The date indicated on the electronic version i
摘自期刊官网 Aims & Scope
研究方向(LetPub):Medicine-Pharmacology (medical)
主编 Pokrovskii M.V.出版商官网
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Neurological Disorders and TreatmentsNeuroscience8.6%
- Nitric Oxide and Endothelin EffectsMedicine8.1%
- Synthesis and biological activityChemistry6.2%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience5.7%
- Cardiac Ischemia and ReperfusionMedicine4.8%
- Neuropeptides and Animal PhysiologyNeuroscience4.6%
- Pain Mechanisms and TreatmentsMedicine4.3%
- Wound Healing and TreatmentsMedicine4.3%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
CiteScore 分区(Scopus,2026 年 6 月版)
| 学科 | 分区 | 排名 | 百分位 |
|---|---|---|---|
| Pharmaceutical Science | Q3 | 131/191 | 31% |
| Pharmacology (medical) | Q4 | 213/278 | 23% |
| Pharmacology | Q4 | 263/328 | 19% |
Scopus 按 CiteScore 在每个学科内为期刊排名,百分位 75 及以上为 Q1,每 25 为一档;与中科院分区是不同体系。LetPub
数据库收录
ScopusDOAJLetPub
国际期刊预警名单:各版本均未列入LetPub
期刊官网自述收录
Web of ScienceCAS出版商官网
其他:Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、Scilit、Naver、Crossref、Semantic Scholar
期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- CiteScore 2026-06
- 1.2LetPub ·
- SJR 2026-06
- 0.2LetPub ·
- SNIP 2026-06
- 0.42LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 23OpenAlex ·
- 两年平均被引
- 0.58OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 450 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 42 | 42 | 132 |
| 2025 | 58 | 58 | 174 |
| 2024 | 43 | 43 | 137 |
| 2023 | 43 | 43 | 165 |
| 2022 | 47 | 47 | 171 |
| 2021 | 38 | 38 | 95 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度(社区反馈)
- 12 WeeksLetPub ·
- 投稿到发表(期刊自报)
- 约 12 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY | |
| LetPub | 无文章处理费 | 无 | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点2 项,摘自作者指南
- 关键词
- ≤ 8 个
- 参考文献格式
- APA 格式
官网政策摘录作者资格、同行评审
- 作者资格
作者须知要求所有论文均应使用语法正确的英文,并请作者确认稿件在投稿前已用流利英文撰写或经专业英文编辑润色。 模型中文摘要
All papers should be in grammatically correct English. Authors are asked to certify that their manuscripts are written in fluent English or edited by a professional English language editor prior to submission.
原文 ↗出版商官网 ·- 同行评审
由于采用双盲同行评审制度,除致编辑信和补充材料外,稿件须以两个单独文件提交。 模型中文摘要
Due to the double-blind peer review system, you have to submit your manuscript (apart from the letter to the editor and supplementary material) as two separate files
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Belgorod State National Research University
- 出版国家或地区
- Bulgaria
- 出版语言
- English
- ISSN
- 2658-381X
- 印刷版 ISSN
- 2500-235X
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Research Results in Pharmacology 的常见问题
Research Results in Pharmacology 的审稿周期多长?
投稿社区反馈的平均审稿速度为约 12 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
Research Results in Pharmacology 的投稿格式要求是什么?
据期刊作者指南:关键词:≤ 8 个;参考文献格式:APA 格式。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Research Results in Pharmacology 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Research Results in Pharmacology 被 Scopus、DOAJ 收录。期刊官网自述还被 Web of Science、CAS 收录,该清单未与各数据库逐一核对。
Research Results in Pharmacology 是开放获取期刊吗?版面费多少?
Research Results in Pharmacology 为钻石开放获取(无 APC)。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。